Loading...
Bevacizumab in Wet AMD treatment: A tribute to the thirteen years of experience from the beginning of the anti-VEGF era in Romania
This study aimed to identify and describe anatomical and functional changes on short (1–3 months) and medium (6–12 months) term after intravitreal injections of bevacizumab (Avastin, Genentech) in patients with choroidal neovascularization (CNV) in the context of exudative form of age-related macula...
Saved in:
| Published in: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880423/ https://ncbi.nlm.nih.gov/pubmed/31798721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7858 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|